Could immune checkpoint drugs fight deadly mold infections? new study aims to find out

NCT ID NCT06285188

First seen Nov 20, 2025 · Last updated Apr 28, 2026 · Updated 21 times

Summary

This study is looking at how the immune system responds to serious mold infections, like those caused by Aspergillus. The goal is to find out which patients might benefit from adding immunotherapy (drugs that boost the immune system) to standard treatment. Researchers will monitor 20 adults with these infections over time, measuring immune cell activity. This is an observational study, not a treatment trial, and aims to guide future therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE FUNGAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Necker Enfants Malades

    RECRUITING

    Paris, 75015, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.